Theraclion SA (ALTHE) Stock Statistics & Valuation Metrics

Theraclion SA has a market cap or net worth of €43.49M. The enterprise value is €37.71.

Theraclion SA has 73,123,314 shares outstanding. The number of shares has decreased by -2.65% in one year.

Theraclion SA’s return on equity (ROE) is 2.20 and return on invested capital (ROIC) is -63.07%.

The current PE Ratio of Theraclion SA is ―. Theraclion SA’s PEG ratio is 0.33.

In the last 12 months, Theraclion SA had revenue of 1.19M and earned -5.69M in profits. Earnings per share was -0.10.

In the last 12 months, operating cash flow was -3.56M and capital expenditures -211.00K, giving a free cash flow of -3.77M billion.

Theraclion SA pays an annual dividend of ―, resulting in a dividend yield of ―

Theraclion SA upcoming earnings date is Oct 14, 2026, TBA (Confirmed).

Theraclion SA as a current ratio of 2.21, with Debt / Equity ratio of -196.64%

In the past 12 months, Theraclion SA has paid -837.00K in taxes.

Theraclion SA EV to EBITDA ratio is -6.38, with an EV/FCF ratio of -5.34.

Theraclion SA has €3.38M in cash and marketable securities with €5.09M in debt, giving a net cash position of -€1.71M billion.

Gross margin is -528.16%, with operating margin of -537.44%, and net profit margin of -479.76%.

The average price target for Theraclion SA is ―, which is 11.43% higher than the current price. The consensus rating is ―